Related Experiment Video
Updated: May 27, 2026
12:55
High-throughput Functional Screening using a Homemade Dual-glow Luciferase Assay
Published on: June 1, 2014
Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery
Pulin Che1, Long Cui, Olaf Kutsch
11 Division of Infectious Diseases, Department of Medicine, University of Alabama, Birmingham, Alabama 35294, USA.
Assay and Drug Development Technologies
|November 5, 2011
Summary
Developing new malaria treatments is crucial due to drug resistance. This study optimized a high-throughput screening assay using Plasmodium falciparum to efficiently discover novel antimalarial compounds.
Area of Science:
- * Parasitology and infectious disease research.
- * Drug discovery and development.
Background:
- * Multidrug-resistant Plasmodium falciparum and emerging artemisinin resistance necessitate novel antimalarial therapies.
- * Southeast Asia is a critical region for monitoring antimalarial drug resistance.
Purpose of the Study:
- * To adapt, miniaturize, optimize, and validate a high-throughput screening assay for antimalarial drug discovery.
- * To establish a robust and reliable assay for large-scale screening of chemical libraries.
Main Methods:
- * Utilized a stable transgenic Plasmodium falciparum line with firefly luciferase expression.
- * Optimized assay conditions including parasitemia and hematocrit in 384-well plates.
- * Validated assay robustness using Z'-value, coefficient variation (CV), and signal-to-background (S/B) ratio with the LOPAC(1280) library.
Main Results:
- * Achieved a robust assay with an average Z'-value >0.7 and CV <10%.
- * Demonstrated a very low background with an S/B ratio up to 71.
- * Confirmed hits using a SYBR Green I-based assay.
Conclusions:
- * The developed assay is robust, reliable, and suitable for high-throughput screening.
- * This assay facilitates efficient identification of potential antimalarial drug candidates.
- * Supports the ongoing search for effective treatments against drug-resistant malaria strains.
